Spectrum of extracellular matrix degrading enzymes in normal and malignantT lymphocytes

Citation
D. Hauzenberger et al., Spectrum of extracellular matrix degrading enzymes in normal and malignantT lymphocytes, ANTICANC R, 19(3A), 1999, pp. 1945-1952
Citations number
44
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTICANCER RESEARCH
ISSN journal
02507005 → ACNP
Volume
19
Issue
3A
Year of publication
1999
Pages
1945 - 1952
Database
ISI
SICI code
0250-7005(199905/06)19:3A<1945:SOEMDE>2.0.ZU;2-H
Abstract
Human T cells produce and release fibronectin degrading neutral serine prot eases with a molecular weight of 50 kD, 70-80 kD (doublet) and 95 kD and ha ve a cell associated 400 kD fibronectin degrading enzyme. In addition, huma n T cells produce proteases with m.w. 50 70-80 kD and 400 kD which degrade laminin. CD 4+ T lymphocytes from a non-malignant cloned human T cell line produce a 92 kD gelatinase (MMP 9) and malignant T cell lines release, in a ddition to the 92 kD gelatinase, low amounts of a 72 kD gelatinase (MMP 2). Purification of the enzymatic activities using benzamidine sepharose yield s a 50 kD and a 70 kD band of which the 50 kD band has fibronectin degradin g capacity. The purified enzymes do not react with monoclonal antibodies to various previously characterized proteolytic enzymes present in T cells. T lymphocytes from a non-malignant cloned human T cell line produce high amo unts of the 50 and 70-80 kD proteases directly after stimulation with anti- CD 3 monoclonal antibodies wherafter the production of these enzymes declin es with time. The expression of the 400 kD fibronectin-degrading protease i s downregulated by crosslinking of alpha 4 beta 1-integrin receptors on T c ells using monoclonal antibodies. Thus, T lymphocytes produce several matri x degrading enzymes with multiple substrate specificities. The expression o f these enzymes is controlled partly by lymphocyte activation signals or by direct signalling via beta 1-integrins.